Funding for this research was provided by:
Enteromed Ltd, 85 Great Portland St, London, W1W 7LT, UK
Text and Data Mining valid from 2019-04-04
Received: 19 October 2018
Accepted: 26 March 2019
First Online: 4 April 2019
: This article contains original research and has not been published or submitted for publication elsewhere. This independent research conducted by Dr. C.A. Howell at the University of Brighton, was funded as research consultancy by the company Enteromed Ltd, the distributor and CRO of Enterosgel in the UK. Dr. C.A. Howell is now employed by the funder and holds an honorary position at the University of Brighton. Professor S.V. Mikhalovsky has consulted for the funder and received compensation. Elena Markaryan is the CEO of Enteromed Ltd. Dr. A.V. Khovanov is an employee of TNK SILMA LLC, manufacturer of Enterosgel in Russia.